tm logo
SIRTEX
Live/Registered
SECTION 71 ACCEPTED

on 15 Jun 2022

Last Applicant/ Owned by

101 Miller Street

NORTH SYDNEY

AU

NSW 2060

Serial Number

79109037 filed on 24th Oct 2011

Registration Number

4252171 registered on 04th Dec 2012

in the Principal Register

Correspondent Address

Gwenn Roos

Gwenn Roos OnsideCounsel/Law Office of Gwenn Roos

Wellesley, MA 02482

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

SIRTEX

Medical research; scientific research for medical purposes; research and development of medical and veterinary products for medical and veterinary purposes, including pharmaceuticals, microcapsules, microparticles, radioactive materials, chemical agents and preparations, cancer treatments and treatments for diseased cells; medical and scientific research relating to molecular sciences, pharmaceuti Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Medical research; scientific research for medical purposes; research and development of medical and veterinary products for medical and veterinary purposes, including pharmaceuticals, microcapsules, microparticles, radioactive materials, chemical agents and preparations, cancer treatments and treatments for diseased cells; medical and scientific research relating to molecular sciences, pharmaceuticals, drugs, chemicals and biotechnology


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposes, namely, for the treatment of cancer; capsules and particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials for medical and pharmaceutical purposes for the treatment of cancer; chemical preparations for medical and pharmaceutical purposes for the treatment of cancer; chemical preparations for veterinary purposes for the treatment of cancer; drugs for medical purposes for the treatment of cancer; microcapsules for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials containing radioactive material for medical therapeutic use for the treatment of cancer; microcapsules containing pharmaceutical, veterinary or medical preparations for the treatment of cancer; microcapsules and microparticles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials adapted to selectively deliver material, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials and microcapsules for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials adapted to selectively deliver material, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ for the treatment of cancer


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79109037

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
31st Aug 2024RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
15th Jun 2022REGISTERED-SEC.71 ACCEPTED
15th Jun 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
31st May 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09th May 2022LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02th Apr 2022RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
05th Dec 2021TEAS SECTION 71 RECEIVED
04th Dec 2021COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11th Nov 2021INTERNATIONAL REGISTRATION RENEWED
09th Apr 2021NEW REPRESENTATIVE AT IB RECEIVED